Cited by 41Genetic Associations and EpidemiologyTreatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults

Open access
Nho, Kwangsik, Ramanan, Vijay K., Horgusluoglu, Emrin, Kim, Sungeun, Inlow, Mark H., Risacher, Shannon L., McDonald, Brenna C., Farlow, Martin R. +7 more·2015·Journal of Alzheimer’s Disease

Abstract

Depressive symptoms are common in older adults and are particularly prevalent in those with or at elevated risk for dementia. Although the heritability of depression is estimated to be substantial, single nucleotide polymorphism-based genome-wide association studies of depressive symptoms have had limited success. In this study, we performed genome-wide gene- and pathway-based analyses of depressive symptom burden. Study participants included non-Hispanic Caucasian subjects (n = 6,884) from three independent cohorts, the Alzheimer's Disease Neuroimaging Initiative (ADNI), the Health and Retirement Study (HRS), and the Indiana Memory and Aging Study (IMAS). Gene-based meta-analysis identified genome-wide significant associations (ANGPT4 and FAM110A, q-value = 0.026; GRM7-AS3 and LRFN5, q-value = 0.042). Pathway analysis revealed enrichment of association in 105 pathways, including multiple pathways related to ERK/MAPK signaling, GSK3 signaling in bipolar disorder, cell development, and immune activation and inflammation. GRM7, ANGPT4, and LRFN5 have been previously implicated in psychiatric disorders, including the GRM7 region displaying association with major depressive disorder. The ERK/MAPK signaling pathway is a known target of antidepressant drugs and has important roles in neuronal plasticity, and GSK3 signaling has been previously implicated in Alzheimer's disease and as a promising therapeutic target for depression. Our results warrant further investigation in independent and larger cohorts and add to the growing understanding of the genetics and pathobiology of depressive symptoms in aging and neurodegenerative disorders. In particular, the genes and pathways demonstrating association with depressive symptoms may be potential therapeutic targets for these symptoms in older adults.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-148009

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nho, K., Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., Callahan, C. M., Hendrie, H. C., Niculescu, A. B., Saykin, A. J., & (ADNI), F. T. A. D. N. I.
Affiliations
  • Indiana University Indianapolis (US)
  • Rose–Hulman Institute of Technology (US)
  • Indiana University School of Medicine (US)
Corresponding author
Saykin, Andrew J.
Venue
Journal of Alzheimer’s Disease
Published
2015-04-13
Volume
45
Issue
4
Pages
1197-1206
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1631734526
Cited by
41
References
64
Citations by year
2026: 3 · 2025: 4 · 2024: 1 · 2023: 6 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 4
FWCI
3.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Michigan
  • National Institutes of Health (UL1TR001108, 5u01ag024904-10)
  • School of Medicine, Indiana University
  • National Institute on Aging (U01-AG-024904, P30AG010133, R01 AG19771, RC2AG036495, U24 AG21886, RC4AG039029, R01AG019771, P30 AG-10133, U01AG009740, U24AG021886)
  • U.S. National Library of Medicine (R00LM011384, K99LM011384)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
depressive symptoms, older adults
MeSH terms
Aged, Depression, Female, Humans, Male, Psychiatric Status Rating Scales, Cohort Studies, White People, Genotyping Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review